NCT03486041

Brief Summary

This study will be the first randomized controlled trial of Comprehensive Behavior Modification (ComB) as a treatment of trichotillomania (TTM). ComB treatment (12 weekly sessions, following a manual developed in an earlier treatment development project) will be compared to Minimal Attention Control among adults (N = 42) with TTM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 3, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

May 10, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
Last Updated

January 13, 2021

Status Verified

January 1, 2021

Enrollment Period

2 years

First QC Date

March 15, 2018

Last Update Submit

January 11, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Massachusetts General Hospital Hairpulling Scale

    7-item self-report measure of TTM symptom severity. Score range = 0 to 28. Higher scores = more severe hairpulling symptoms in past week.

    baseline (week 0), week 6, week 12, week 25, week 38

  • Change in National Institute of Mental Health (NIMH) Trichotillomania Severity and Impairment Scales

    interviewer ratings \[to be completed by independent evaluator masked to experimental condition\] of TTM symptoms and impairment. Scores on the TSS (symptom severity) range 0 to 25, higher scores reflecting more severe symptoms. Scores on the TIS (impairment) range 0 to 10, higher scores reflecting greater impairment associated with hairpulling

    baseline (week 0), week 6, week 12, week 25, week 38

  • Change in Trichotillomania Diagnostic Interview (modified for DSM-5)

    structured diagnostic interview to determine presence/absence of TTM

    baseline (week 0), week 6, week 12, week 25, week 38

Secondary Outcomes (4)

  • Alopecia rating

    baseline (week 0), week 6, week 12, week 25, week 38

  • Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version [Revised by Keuthen et al.]

    baseline (week 0), week 6, week 12, week 25, week 38

  • Client Satisfaction Questionnaire

    week 6, week 12, week 25, week 38

  • Stop Signal task

    baseline (week 0), week 6, week 12

Study Arms (2)

immediate ComB

EXPERIMENTAL

12 weekly sessions of ComB treatment in individual therapy, following a detailed manual.

Behavioral: Comprehensive Behavior Modification

Minimal Attention Control

PLACEBO COMPARATOR

Weekly brief phone call from therapist to check on participant safety, medication changes if any, and recent stressors. After week 12, participants in this arm received delayed ComB \[as in the Experimental condition -- 12 weekly sessions of individual therapy for TTM based on ComB model\].

Behavioral: Attention

Interventions

Behavior therapy approach to BFRBs involving targeted intervention tactics chosen in accordance with the modality of functioning (ex: Sensory, Cognitive.....) seeming to cause the most frequent and problematic urges to engage in the BFRB. Therapist and client work together, using careful assessments including detailed self-monitoring, to determine what behavioral methods will suffice for lasting change.

immediate ComB
AttentionBEHAVIORAL

Weekly brief calls from therapist to check on safety and clinical status. No focus on TTM.

Minimal Attention Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • diagnosed with Trichotillomania
  • medication type and dosage \[if any\] stable for at least 3 months

You may not qualify if:

  • active suicidality
  • probable bipolar disorder
  • probable psychosis
  • other pressing clinical problem requiring immediate treatment
  • current psychotherapy and unable/unwilling to discontinue

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

American University

Washington D.C., District of Columbia, 20016, United States

Location

Related Publications (1)

  • Carlson EJ, Malloy EJ, Brauer L, Golomb RG, Grant JE, Mansueto CS, Haaga DAF. Comprehensive Behavioral (ComB) Treatment of Trichotillomania: A Randomized Clinical Trial. Behav Ther. 2021 Nov;52(6):1543-1557. doi: 10.1016/j.beth.2021.05.007. Epub 2021 Jun 3.

MeSH Terms

Conditions

Trichotillomania

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Obsessive-Compulsive DisorderAnxiety DisordersMental DisordersDisruptive, Impulse Control, and Conduct Disorders

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The project coordinator at each site will conduct baseline assessments. All later assessments will be conducted by different research assistants, masked to experimental condition of the participant.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Immediate ComB and MAC participants will each be assessed at baseline (week 0). ComB will begin weekly therapy sessions, and MAC will receive weekly phone check-ins. All will be assessed at week 6 \[mid-treatment\] and week 12 \[end of controlled phase\]. After week 12, ComB enters maintenance and MAC participants start to receive delayed ComB. There is another assessment at week 25 (3-month followup for immediate ComB, post-ComB for MAC) and a final assessment at week 38 (6-month followup for immediate ComB, 3-month followup for MAC).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychology

Study Record Dates

First Submitted

March 15, 2018

First Posted

April 3, 2018

Study Start

May 10, 2018

Primary Completion

April 30, 2020

Study Completion

April 30, 2020

Last Updated

January 13, 2021

Record last verified: 2021-01

Locations